P0.1/PetCO2 slope as an indirect measurement of CO2 hypersensitivity in patients with central sleep apnoeas.

A. Ortiz Reyes (Oviedo, Spain), R. Fernandez Álvarez (Oviedo, Spain), G. Rubinos Cuadrado (Oviedo, Spain), I. Ruiz Alvarez (Oviedo, Spain), M. Iscar Urrutia (Oviedo, Spain), M. Vazquez Lopez (Oviedo, Spain), P. Casan Clara (Oviedo, Spain)

Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ortiz Reyes (Oviedo, Spain), R. Fernandez Álvarez (Oviedo, Spain), G. Rubinos Cuadrado (Oviedo, Spain), I. Ruiz Alvarez (Oviedo, Spain), M. Iscar Urrutia (Oviedo, Spain), M. Vazquez Lopez (Oviedo, Spain), P. Casan Clara (Oviedo, Spain). P0.1/PetCO2 slope as an indirect measurement of CO2 hypersensitivity in patients with central sleep apnoeas.. 884

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep
Source: Eur Respir Rev 2007; 16: 115-124
Year: 2007



Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients
Source: Eur Respir J 2004; 23: 891-895
Year: 2004



Impact of continuous positive airways pressure treatment on autonomic nervous system activity in patients with sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

The influence of continuous positive airway pressure (CPAP) on response to incremental exercise in sleep apnea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 567s
Year: 2004

Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Parallel decrease in airway patency, monitored with forced oscillation technique, and inspiratory central drive, estimated by mouth occlusion pressure (P0.1), during sleep apnea in obese patients
Source: Eur Respir J 2001; 18: Suppl. 33, 332s
Year: 2001

Nocturnal energy expenditure, heat flux and galvanic skin response in mild and moderate-to-severe obstructive sleep apnea (OSA)
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008

The control of breathing in central sleep apnoea chemo-sensitivity, apnoeic thresholds, loop gain and all that
Source: ERS Conference
Year: 2015

Efficacy of daytime continuous positive airway pressure titration in severe obstructive sleep apnoea
Source: Eur Respir J 2001; 18: 535-541
Year: 2001



Twenty years compliance with continuous positive air pressure treatment in patients with severe obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019

Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Exploring the impact of continuous positive airway pressure treatment on biological clock disruption in obstructive sleep apnea patients
Source: Sleep and Breathing Conference 2021
Year: 2021




Humidified nasal continuous positive airway pressure in obstructive sleep apnoea
Source: Eur Respir J 2003; 22: 258-262
Year: 2003



Treatment options for central sleep apnea (including auto-CPAP)
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005

Proportional positive airway pressure: a new concept to treat obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 467-473
Year: 2001



Is there a metabolic effect of continuous positive airway pressure in sleep apnoea? Adherence should not be underestimated
Source: Eur Respir J 2009; 34: 1209-1210
Year: 2009


Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Nasal continuous positive airway pressure: influence on digital volume pulse in obstructive sleep apnoea patients
Source: Eur Respir J 2012; 39: 1127-1135
Year: 2012



The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015